학술논문

Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion
Case Report
Document Type
Clinical report
Source
Neurology and Therapy. March 2022, Vol. 11 Issue 1, p499, 7 p.
Subject
France
Language
English
Abstract
Author(s): Charlotte Héraud [sup.1] , Nicolas Capet [sup.1] [sup.2] , Michaël Levraut [sup.2] [sup.3] , Robin Hattenberger [sup.1] , Véronique Bourg [sup.1] , Pierre Thomas [sup.1] , Lydiane Mondot [sup.2] [...]
Introduction Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is scarce and usually presents as meningoencephalomyelitis. Here, we offer the case of an atypical presentation of GFAP-astrocytopathy. Case Presentation We report the case of a 26-year-old woman admitted to our neurology department for a 3-week progressive and worsening neurologic picture, with secondary worsening. Initial imaging showed a Mild Encephalitis with Reversible Splenium of corpus callosum lesion (MERS). Full infectious and autoimmune workup then revealed positivity of GFAP antibodies, leading us to diagnose GFAP astrocytopathy. Discussion Our case is the first reported association between MERS and GFAP astrocytopathy in an adult patient. Clinical presentation of GFAP astrocytopathy usually includes various neurologic symptoms and can lead to misdiagnosis.